Albiruni Abdul Razak (Albiruni Razak, Albiruni R A Razak, Albiruni R Abdul Razak)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Topics

Metastatic Renal Cell Carcinoma

Top Venues

Cancer discovery

JCO precision oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Eric Y Zhao, Enrique Sanz-Garcia, Zhihui Amy Liu, Derek Wong, Kayla Marsh, Albiruni Abdul Razak, Anna Spreafico, Philippe L Bedard, Aaron Richard Hansen, Stéphanie Lheureux, Dax Torti, Bernard Lam, Shih Yu Cindy Yang, Justin M Burgener, Ping Luo, Yong Zeng, Nicholas Cheng, Phillip Awadalla, Scott V Bratman, Pamela S Ohashi, Trevor J Pugh, Lillian L Siu
Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors. Cancer discovery 14 (6) (2024)
Eric Y Zhao, Enrique Sanz-Garcia, Zhihui Amy Liu, Derek Wong, Kayla Marsh, Albiruni Abdul Razak, Anna Spreafico, Philippe L Bedard, Aaron Richard Hansen, Stéphanie Lheureux, Dax Torti, Bernard Lam, Shih Yu Cindy Yang, Justin M Burgener, Ping Luo, Yong Zeng, Nicholas Cheng, Phillip Awadalla, Scott V Bratman, Pamela S Ohashi, Trevor J Pugh, Lillian L Siu
Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors. Cancer discovery 14 (6) (2024)
Eric Y Zhao, Enrique Sanz-Garcia, Zhihui Amy Liu, Derek Wong, Kayla Marsh, Albiruni Abdul Razak, Anna Spreafico, Philippe L Bedard, Aaron Richard Hansen, Stéphanie Lheureux, Dax Torti, Bernard Lam, Shih Yu Cindy Yang, Justin M Burgener, Ping Luo, Yong Zeng, Nicholas Cheng, Phillip Awadalla, Scott V Bratman, Pamela S Ohashi, Trevor J Pugh, Lillian L Siu
Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors. Cancer discovery 14 (6) (2024)
André B P van Kuilenburg, Albiruni Abdul Razak, Matthew H Taylor, Todd M Bauer, Breelyn A Wilky, Javier Martín-Broto, Alejandro Falcón Gonzalez, Piotr Lukasz Rutkowski, Bartlomiej Szostakowski, Thierry Alcindor, Ramy R Saleh, Sofia Genta, Silvia Stacchiotti, Michiel Adreanus van de Sande, Andrew J Wagner, Nicholas M Bernthal, Lara E Davis, Jacqueline Vuky, Christopher Tait, Bahar Matin, Supraja Narasimhan, Maitreyi G Sharma, Rodrigo Ruiz-Soto, Matthew L Sherman, William D Tap
CSF1R Inhibition in Patients With Advanced Solid Tumors or Tenosynovial Giant Cell Tumor: A Phase 1 Study of Vimseltinib. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Alberto Hernando-Calvo, S Y Cindy Yang, Maria Vila-Casadesús, Ming Han, Zhihui Amy Liu, A Hal K Berman, Anna Spreafico, Albiruni Abdul Razak, Stéphanie Lheureux, Aaron Richard Hansen, Deborah Lo Giacco, Farnoosh Abbas-Aghababazadeh, Judith Matito, Benjamin Haibe-Kains, Trevor J Pugh, Scott V Bratman, Meenakshi Malhotra, Roger Berche, Omar Saavedra, Elena Garralda, Sawako Elston, Lillian L Siu, Pamela S Ohashi, Ana Vivancos, Philippe L Bedard
Combined Transcriptome and Circulating Tumor DNA Longitudinal Biomarker Analysis Associates With Clinical Outcomes in Advanced Solid Tumors Treated With Pembrolizumab. JCO precision oncology 8 (2024)
Alberto Hernando-Calvo, S Y Cindy Yang, Maria Vila-Casadesús, Ming Han, Zhihui Amy Liu, A Hal K Berman, Anna Spreafico, Albiruni Abdul Razak, Stéphanie Lheureux, Aaron Richard Hansen, Deborah Lo Giacco, Farnoosh Abbas-Aghababazadeh, Judith Matito, Benjamin Haibe-Kains, Trevor J Pugh, Scott V Bratman, Meenakshi Malhotra, Roger Berche, Omar Saavedra, Elena Garralda, Sawako Elston, Lillian L Siu, Pamela S Ohashi, Ana Vivancos, Philippe L Bedard
Combined Transcriptome and Circulating Tumor DNA Longitudinal Biomarker Analysis Associates With Clinical Outcomes in Advanced Solid Tumors Treated With Pembrolizumab. JCO precision oncology 8 (2024)
Eric Y Zhao, Enrique Sanz-Garcia, Zhihui Amy Liu, Derek Wong, Kayla Marsh, Albiruni Abdul Razak, Anna Spreafico, Philippe L Bedard, Aaron Richard Hansen, Stéphanie Lheureux, Dax Torti, Bernard Lam, Shih Yu Cindy Yang, Justin M Burgener, Ping Luo, Yong Zeng, Nicholas Cheng, Phillip Awadalla, Scott V Bratman, Pamela S Ohashi, Trevor J Pugh, Lillian L Siu
Early changes in tumor-naive cell-free methylomes and fragmentomes predict outcomes in pembrolizumab-treated solid tumors. Cancer discovery (2024)
Abdulazeez Salawu, Ben X Wang, Ming Han, Caryn Geady, Alya Heirali, Hal K Berman, Thomas D Pfister, Alberto Hernando-Calvo, Esmail Mutahar Al-Ezzi, Lee-Anne Stayner, Abha A Gupta, Olubukola Ayodele, Bernard Lam, Aaron Richard Hansen, Anna Spreafico, Philippe L Bedard, Marcus O Butler, Lisa Avery, Bryan Coburn, Benjamin Haibe-Kains, Lillian L Siu, Albiruni Abdul Razak
Safety, immunologic and clinical activity of Durvalumab in combination with Olaparib or Cediranib in advanced leiomyosarcoma: Results of the DAPPER clinical trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Enrique Sanz-Garcia, Sofia Genta, Xiaoxi Chen, Qiuxiang Ou, Daniel Vilarim Araújo, Albiruni Abdul Razak, Aaron Richard Hansen, Anna Spreafico, Hua Bao, Xue Wu, Lillian L Siu, Philippe L Bedard
Tumor-Naïve Circulating Tumor DNA as an Early Response Biomarker for Patients Treated With Immunotherapy in Early Phase Clinical Trials. JCO precision oncology 7 (2023)
Mrinal M Gounder, Albiruni Abdul Razak, Neeta Somaiah, Sant Chawla, Javier Martín-Broto, Giovanni Grignani, Scott M Schuetze, Bruno Vincenzi, Andrew J Wagner, Bartosz Chmielowski, Robin L Jones, Richard F Riedel, Silvia Stacchiotti, Elizabeth Trice Loggers, Kristen N Ganjoo, Axel Le Cesne, Antoine Italiano, Xavier García Del Muro Solans, Melissa Burgess, Sophie Piperno-Neumann, Christopher Ryan, Mary F Mulcahy, Charles Forscher, Nicolas Penel, Scott H Okuno, Anthony D Elias, Lee Hartner, Tony Philip, Thierry Alcindor, Bernd Kasper, Peter Reichardt, Lore D F Lapeire, Jean Yves Blay, Christine Chevreau, Claudia Maria Valverde Morales, Gary K Schwartz, James L Chen, Hari Deshpande, Elizabeth J Davis, Garth Nicholas, Stefan Gröschel, Helen Hatcher, Florence Duffaud, Antonio Casado Herráez, Roberto Diaz Beveridge, Giuseppe Badalamenti, Mikael Eriksson, Christian F Meyer, Margaret von Mehren, Brian Andrew Van Tine, Katharina S Götze, Filomena Mazzeo, Alexander Yakobson, Aviad Zick, Alexander T J Lee, Anna Estival Gonzalez, Andrea Napolitano, Mark A Dickson, Dayana Michel, Chang-Ting Meng, Lingling Li, Jianjun Liu, Osnat Ben-Shahar, Dane R Van Domelen, Christopher J Walker, Hua Chang, Yosef Landesman, Jatin J Shah, Sharon Shacham, Michael G Kauffman, Steven Attia
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (22) (2022)
James Nguyen, Naoko Takebe, Shivaani Kummar, Albiruni Abdul Razak, Sant P Chawla, Suzanne George, Shreyaskumar R Patel, Mary Louise Keohan, Sujana Movva, Geraldine O'Sullivan Coyne, Khanh T Do, Lamin Jawara, Brooke Augustine, Seth M Steinberg, Laura Kuhlmann, Susan Percy Ivy, James H Doroshow, Helen X Chen
Randomized Phase 2 Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Sebastian Bauer, Robin L Jones, Jean Yves Blay, André B P van Kuilenburg, Suzanne George, Patrick Schöffski, Margaret von Mehren, John R Zalcberg, Yoon-Koo Kang, Albiruni Abdul Razak, Jonathan C Trent, Steven Attia, Axel Le Cesne, Ying Su, Julie Meade, Tao Wang, Matthew L Sherman, Rodrigo Ruiz-Soto, Michael C Heinrich
Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (34) (2022)
Tira Jing Ying Tan, Michael Rheaume, Lisa Wang, Helen Chow, Anna Spreafico, Aaron Richard Hansen, Albiruni Abdul Razak, Lillian L Siu, Philippe L Bedard
Referrals to a Phase I Clinic and Trial Enrollment in the Molecular Screening Era. The oncologist 24 (7) (2019)